Axel Rouch

ORCID: 0000-0001-5638-9711
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lung Cancer Diagnosis and Treatment
  • Esophageal Cancer Research and Treatment
  • Lung Cancer Treatments and Mutations
  • Spinal Fractures and Fixation Techniques
  • Dermatological and Skeletal Disorders
  • Vascular Malformations and Hemangiomas
  • Head and Neck Surgical Oncology
  • Trauma Management and Diagnosis
  • Shoulder and Clavicle Injuries
  • Bladder and Urothelial Cancer Treatments
  • Osteomyelitis and Bone Disorders Research
  • Mast cells and histamine
  • Neurological diseases and metabolism
  • Gastric Cancer Management and Outcomes
  • Vascular Anomalies and Treatments
  • Cancer Immunotherapy and Biomarkers
  • Tracheal and airway disorders
  • Radiomics and Machine Learning in Medical Imaging
  • Pectus Deformity Diagnosis and Treatment

Université de Toulouse
2024-2025

Hôpital Larrey
2019-2024

Centre Hospitalier Universitaire de Toulouse
2019-2022

Centre de Recherche en Cancérologie de Toulouse
2022

Inserm
2022

Centre National de la Recherche Scientifique
2022

Université Toulouse III - Paul Sabatier
2019

Surgery is the cornerstone of treatment for early-stage non-small cell lung cancer (NSCLC). The concept "uncertain resection" (R(un)) describes cases where complete tumor excision with clear margins achieved but without comprehensive lymph node assessment or pleural cytology. This study aimed to establish R(un) as a prognostic factor in localized NSCLC patients and explore its heterogeneity. single-center retrospective was conducted at Toulouse University Hospital. Consecutive who underwent...

10.1016/j.athoracsur.2025.02.004 article EN cc-by The Annals of Thoracic Surgery 2025-02-01

Mast cells (MCs) are multifaceted innate immune often present in the tumor microenvironment (TME). However, MCs have been only barely characterized studies focusing on global infiltrate phenotyping. Consequently, their role cancer is still poorly understood. Furthermore, prognosis value confusing since associated with good and bad (or both) depending type. In this pilot study performed a surgical cohort of 48 patients Non-Small Cell Lung Cancer (NSCLC), we MC population within TME matching...

10.3390/cancers14061394 article EN Cancers 2022-03-09

physiotherapists will be necessary to achieve optimal functional outcomes and avoid chest wall pulmonary complications.

10.1136/tsaco-2023-001259 article EN cc-by-nc Trauma Surgery & Acute Care Open 2024-07-01

Haemangioma of the ribs is considered an extremely rare benign tumour. Here, we present a case young male with left tenth rib haemangioma vascularised by costal artery giving Adamkiewicz presented as chronic cough. This was successfully treated through preoperative embolisation and surgical resection. A angiogram performed to identify origin Adamkiewicz. The final diagnosis confirmed histopathologically. There were no complications in postoperative course recurrence during 12 months follow-up.

10.1136/bcr-2024-260257 article EN BMJ Case Reports 2024-09-01

We described patients with microscopic residual disease (R1) operated on for non-small-cell lung cancer (NSCLC) and investigated predictive factors R1. also examined prognostic overall survival in these patients.From June 2003 to December 2019, a total of 2595 benefited from an anatomical resection operation NSCLC our department. All preoperative data were prospectively collected Epithor, the French thoracic surgery national database. pre-, per- postoperative care followed current...

10.1093/ejcts/ezac037 article EN European Journal of Cardio-Thoracic Surgery 2022-01-25

10.1016/j.anorl.2019.09.012 article RO publisher-specific-oa European Annals of Otorhinolaryngology Head and Neck Diseases 2019-09-30

10.1016/j.aforl.2019.05.005 article FR publisher-specific-oa Annales françaises d Oto-rhino-laryngologie et de Pathologie Cervico-faciale 2019-12-01
Coming Soon ...